Evidence map›Paper›PMID 31419437›Full record

ArticleJournal of molecular and cellular cardiology2019

A small-molecule LF3 abrogates β-catenin/TCF4-mediated suppression of Na

Limei Zhao, Lihua Sun, Yan Lu, Faqian Li, Haodong Xu

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Limei ZhaoDepartment of Pathology, Center for Cardiovascular Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 90105, United States of America.
Lihua SunDepartment of Pathology, Center for Cardiovascular Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 90105, United States of America.
Yan LuDepartment of Pathology, Center for Cardiovascular Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 90105, United States of America.
Faqian LiDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, United States of America.
Haodong XuDepartment of Pathology, Center for Cardiovascular Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 90105, United States of America. Electronic address: xuh8@uw.edu.
University of Washington · USUniversity of Minnesota · US

Funding

TCF7L2 isoforms in canonical Wnt signaling during cardiac hypertrophy and failureR01HL153403 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LI, FAQIAN · 2021 to 2025
$2.4M
WNT/BETACANTENIN SIGNALING AND CARDIAC ION CHANNELSR01HL122793 · NHLBI · UNIVERSITY OF WASHINGTON · PI XU, HAODONG · 2015 to 2019
$2.0M
Nuclear beta-catenin signaling in the heartR01HL111480 · NHLBI · UNIVERSITY OF ROCHESTER · PI LI, FAQIAN · 2012 to 2016
$1.9M
NHLBI NIH HHS R01 HL111480NHLBI NIH HHS R01 HL122793NHLBI NIH HHS R01 HL153403
6 · The paper itself

Abstract

Increased nuclear β-catenin interacting with T-cell factor 4 (TCF4) affects the expression of target genes including SCN5A in ischemic heart disease, which is characterized by frequent ventricular tachycardia/fibrillation. A complex of β-catenin and TCF4 inhibits cardiac Na

Indexed as

AnimalsBenzenesulfonamidesbeta CateninCell NucleusDisease Models, AnimalGene Expression RegulationHEK293 CellsHumansMiceMultiprotein ComplexesMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelPromoter Regions, GeneticSulfonamidesTranscription Factor 7-Like 2 ProteinWnt Signaling PathwayBenzenesulfonamidesbeta CateninMultiprotein ComplexesNAV1.5 Voltage-Gated Sodium ChannelScn5a protein, mouseSulfonamidesTCF7L2 protein, humanTranscription Factor 7-Like 2 ProteinInhibitorNa(+) channelNa(V)1.5TCF4β-Catenin

Identifiers

PMID31419437
PMCPMC7088444
OpenAlexW2967966614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.